-
ABL (9q34)/BCR(22q11)-t(9;22)(q34;q11)
PBC030
ABL (9q34)/BCR(22q11)-t(9;22)(q34;q11)
₹3300 -
Beta THALASSEMIA (23 Mutations)
PPC002
Beta THALASSEMIA (23 Mutations)
₹8500 -
CBFß (16q22) and MYH11 (16p13) (inv(16)(p13;q22))
PPC024
CBFß (16q22) and MYH11 (16p13) (inv(16)(p13;q22))
₹3300 -
CYSTIC FIBROSIS (r)F 508/CFTRF508
PPC003
CYSTIC FIBROSIS (r)F 508/CFTRF508
₹6000 -
DUCHENNE MUSCULAR DYSTROPHY (DMD) (26 exons)
PPC004
DUCHENNE MUSCULAR DYSTROPHY (DMD) (26 exons)
₹8000 -
E2A(19p13) and PBX1(1q23) - t(1;19)(q23;p13) - ALL
PPC005
E2A(19p13) and PBX1(1q23) - t(1;19)(q23;p13) - ALL
₹5500 -
FACTOR II (PROTHROMBIN) Mutation Study
PPC007
FACTOR II (PROTHROMBIN) Mutation Study
₹3750 -
FLT3 – ITD (Fetal Liver Tyrosine Kinase)
PPC027
FLT3 – ITD (Fetal Liver Tyrosine Kinase)
₹5500 -
Fragile X Syndrome (FMRI Gene)
PPC009
Fragile X Syndrome (FMRI Gene)
₹6500 -
IRMA (Imatinib Resistance Mutation Analysis) in CML
PPC011
IRMA (Imatinib Resistance Mutation Analysis) in CML
₹9500